Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wege

Showing results (491-500 of 514) with videos related to

Pageof 52
Sort By:
Hepatology (Baltimore, Md.)|July 19, 2024
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatmentCiro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, et al.
JAMA Oncology|July 18, 2024
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B DysfunctionClaudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2023
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2023
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|February 16, 2024
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|January 9, 2024
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|February 16, 2024
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|January 9, 2024
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
The Lancet. Digital Health|February 13, 2026
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort studyMathew Vithayathil, Giulia Francesca Manfredi, Antonio D'Alessio, et al.
Zeitschrift Fur Gastroenterologie|March 10, 2025
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Pageof 52

Showing results (491-500 of 514) with videos related to

Sort By:
Pageof 52
Hepatology (Baltimore, Md.)|July 19, 2024
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatmentCiro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, et al.
JAMA Oncology|July 18, 2024
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B DysfunctionClaudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2023
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2023
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|February 16, 2024
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|January 9, 2024
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|February 16, 2024
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift Fur Gastroenterologie|January 9, 2024
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
The Lancet. Digital Health|February 13, 2026
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort studyMathew Vithayathil, Giulia Francesca Manfredi, Antonio D'Alessio, et al.
Zeitschrift Fur Gastroenterologie|March 10, 2025
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Pageof 52